135 related articles for article (PubMed ID: 34108312)
1. [Chronic-phase chronic myeloid leukemia with intracranial hemorrhage complicated with tumor lysis syndrome].
Oyama C; Arakawa Y; Ikeda Y; Aoki T; Kubota Y; Isobe K; Mori M; Kurihara J; Koh K
Rinsho Ketsueki; 2021; 62(5):346-351. PubMed ID: 34108312
[TBL] [Abstract][Full Text] [Related]
2. Sudden Intracranial Hemorrhage in a Patient With Atypical Chronic Myeloid Leukemia in Chronic Phase.
Kouzuki K; Umeda K; Saida S; Kato I; Hiramatsu H; Funaki T; Kanda K; Muramatsu H; Yoshida K; Ogawa S; Adachi S
J Pediatr Hematol Oncol; 2018 Nov; 40(8):e553-e556. PubMed ID: 29227326
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous tumor lysis syndrome in a patient with chronic myeloid leukemia treated successfully with allopurinol.
Gartenberg A; Winkel M; Leonard N
Am J Emerg Med; 2024 Apr; 78():242.e1-242.e3. PubMed ID: 38007380
[TBL] [Abstract][Full Text] [Related]
4. Tumor lysis syndrome soon after treatment with hydroxyurea followed by nilotinib in two patients with chronic-phase chronic myelogenous leukemia.
Hua J; Iwaki Y; Inoue M; Hagihara M
Int J Hematol; 2013 Aug; 98(2):243-6. PubMed ID: 23649869
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group.
Hehlmann R; Heimpel H; Hasford J; Kolb HJ; Pralle H; Hossfeld DK; Queisser W; Löffler H; Hochhaus A; Heinze B
Blood; 1994 Dec; 84(12):4064-77. PubMed ID: 7994025
[TBL] [Abstract][Full Text] [Related]
6. Acute tumor lysis syndrome in a patient with chronic myelogenous leukemia in blast crisis: role of high-dose Ara-C.
Przepiorka D; Gonzales-Chambers R
Bone Marrow Transplant; 1990 Oct; 6(4):281-2. PubMed ID: 2085702
[TBL] [Abstract][Full Text] [Related]
7. Intracranial Hemorrhage in a Pediatric Patient with Chronic Myeloid Leukemia in Chronic Phase: A Case Report.
Takahashi N; Sano H; Mochizuki K; Kobayashi S; Ohara Y; Kikuta A
Case Rep Oncol; 2021; 14(1):525-530. PubMed ID: 33976629
[TBL] [Abstract][Full Text] [Related]
8. A case of non-Hodgkin lymphoma in a patient with chronic myeloid leukemia.
Găman AM; Dobrea C; Rotaru I
Rom J Morphol Embryol; 2013; 54(4):1141-5. PubMed ID: 24399014
[TBL] [Abstract][Full Text] [Related]
9. [Pure red cell aplasia occurring during the course of chronic myelogenous leukemia].
Yasuyama M; Kawauchi K; Takei K; Ogasawara T; Ohkawa S
Rinsho Ketsueki; 2004 Jan; 45(1):66-71. PubMed ID: 14999937
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea and splenic irradiation-induced tumour lysis syndrome: a case report and review of the literature.
Chen SW; Hwang WS; Tsao CJ; Liu HS; Huang GC
J Clin Pharm Ther; 2005 Dec; 30(6):623-5. PubMed ID: 16336296
[TBL] [Abstract][Full Text] [Related]
12. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement].
Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Mori H; Niikura H; Omine M; Fujita K
Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group.
Hehlmann R; Heimpel H; Hasford J; Kolb HJ; Pralle H; Hossfeld DK; Queisser W; Löffler H; Heinze B; Georgii A
Blood; 1993 Jul; 82(2):398-407. PubMed ID: 8329700
[TBL] [Abstract][Full Text] [Related]
14. U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.
Cohen MH; Johnson JR; Pazdur R
Clin Cancer Res; 2005 Jan; 11(1):12-9. PubMed ID: 15671523
[TBL] [Abstract][Full Text] [Related]
15. Tumor lysis syndrome.
Ezzone SA
Semin Oncol Nurs; 1999 Aug; 15(3):202-8. PubMed ID: 10461705
[TBL] [Abstract][Full Text] [Related]
16. Management of life-threatening pulmonary leukostasis with single agent imatinib mesylate during CML myeloid blast crisis.
Leis JF; Primack SL; Schubach SE; Curtin PT; Druker BJ; Maziarz RT
Haematologica; 2004 Sep; 89(9):ECR30. PubMed ID: 15377482
[TBL] [Abstract][Full Text] [Related]
17. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
Qing X; Qing A; Ji P; French SW; Mason H
Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
[TBL] [Abstract][Full Text] [Related]
18. Incidence and treatment of tumor lysis syndrome in patients with acute leukemia.
Razis E; Arlin ZA; Ahmed T; Feldman EJ; Puccio C; Cook P; Chun HG; Helson L; Mittelman A
Acta Haematol; 1994; 91(4):171-4. PubMed ID: 7976113
[TBL] [Abstract][Full Text] [Related]
19. Chronic myelogenous leukemia in the chronic phase with lymph node swelling which represented extramedullary involvement composed of cells at different stages of maturation.
Kobayashi Y; Tanaka T; Kawata E; Akaogi T
Rinsho Byori; 2011 Apr; 59(4):360-3. PubMed ID: 21618900
[TBL] [Abstract][Full Text] [Related]
20. [Bone marrow aplasia without blast crisis in a case of CML of 10-year survival].
Shiga Y; Yokoyama A; Ishibashi T; Shichishima T; Abe R; Yui T; Kimura H; Matsuda S; Uchida T; Kariyone S
Rinsho Ketsueki; 1989 May; 30(5):752-6. PubMed ID: 2795887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
